Shlokka Dyes reported a 50.6% decline in net profit after tax to ₹495.96 lakh for FY26, down from ₹1,004.20 lakh in the previous year. The reactive dyes manufacturer attributed the contraction to volatility in raw material costs, subdued export demand, and restricted working capital deployment following its initial public offer.

Revenue from operations fell 20.8% year-on-year to ₹8,194.13 lakh, compared to ₹10,342.62 lakh in FY25. Despite the dip in profitability, the company’s net worth strengthened significantly from ₹2,724.03 lakh to ₹8,536.37 lakh due to the infusion of IPO proceeds.

Financial Performance

The company’s total income decreased to ₹8,289.81 lakh from ₹10,345.46 lakh in the prior period. Cost of materials consumed stood at ₹7,543.57 lakh, while manufacturing and operating costs rose to ₹310.89 lakh from ₹166.82 lakh. Finance costs declined slightly to ₹241.62 lakh from ₹280.43 lakh.

IPO Proceeds and Utilization

Shlokka Dyes raised gross proceeds of ₹5,778.86 lakh through its IPO in October 2025. As of March 31, 2026, the company had utilized ₹5,389.69 lakh, with ₹389.18 lakh remaining unutilized. The statutory auditors noted deviations in the utilization of funds, specifically an excess deployment of ₹1,256.83 lakh towards working capital requirements beyond the prospectus allocation.

Additionally, the monitoring agency reported that ₹2,179.00 lakh was transferred to third parties without board authorization. The company recovered ₹2,079.00 lakh of this amount by March 31, 2026, with legal action ongoing for the remaining ₹100.00 lakh.

What the Numbers Show

A significant divergence exists between the company’s top-line revenue and its related-party trade receivables. While total revenue declined by 20.8%, trade receivables increased by 19.2% to ₹5,407.84 lakh. Notably, receivables from related parties, primarily M/s. Equinox Impex, constituted ₹3,256.03 lakh of the total, indicating a high concentration of credit exposure within the promoter group despite overall lower sales volumes.

Corporate Governance and AGM

The company scheduled its fifth annual general meeting for September 24, 2026, to be held via video conferencing. Key agenda items include the re-appointment of Chairman & Managing Director Vaibhav Pravinchandra Shah and the appointment of Arpit Tiwari as an independent director. The board also seeks shareholder approval for borrowing powers and creation of charges up to an aggregate limit of ₹300 crore under Sections 180(1)(a) and 180(1)(c) of the Companies Act, 2013.

No dividend was recommended for FY26 as the board opted to conserve resources for future growth initiatives, including the recent acquisition of M/s. Equinox Impex’s business undertaking.

Shlokka Dyes Limited company name has approved the acquisition of the entire business undertaking of Equinox Impex (EI) on a slump sale basis for an aggregate cash consideration of ₹3,67,49,248.90. The Board of Directors ratified the deal at a meeting held on July 31, 2026, marking a strategic move to integrate EI’s export trading functions with Shlokka’s existing manufacturing operations in synthetic organic dyes. This consolidation is expected to enhance operational synergies, expand market access, and eliminate duplication of administrative functions between the two entities.

The transaction is structured as a related party transaction since EI is a sole proprietorship concern owned by Mr. Vaibhav Pravinchandra Shah, who serves as the Managing Director of Shlokka Dyes Limited. The total consideration comprises ₹2,23,24,031.81 towards the business undertaking excluding the trademark and ₹1,44,25,217.09 towards the trademark. The valuation was determined on an arm’s length basis using independent reports from Mr. Abhishek Chhajed, an IBBI Registered Valuer. The deal does not require shareholder approval as it falls below the materiality thresholds prescribed under Regulation 23 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Rule 15(3) of the Companies (Meetings of Board and its Powers) Rules, 2014.

Equinox Impex is engaged in the manufacturing, processing, and export of synthetic organic dyes and allied chemical products to customers in India and abroad. The entity reported a turnover of ₹47.01 crore in FY26, down from ₹75.69 crore in FY25 and ₹57.20 crore in FY24. Despite the fluctuation in turnover, EI maintained consistent profitability, with Profit After Tax (PAT) ranging between ₹0.27 crore and ₹0.34 crore over the last three fiscal years. The acquisition includes the transfer of all running operations, assets, liabilities, and the trademark "EQUINOX" (application no. 6661341 filed on October 9, 2024).

The primary objectives of the acquisition include achieving business synergy by integrating export trading with manufacturing, eliminating group conflict of interest by consolidating promoter group businesses under the listed entity, and improving operational efficiency. Management stated that the acquisition will bring EI’s existing export customer relationships directly under Shlokka Dyes, thereby strengthening the company’s export revenue base and geographic diversification. The transaction is expected to be earnings accretive and will not have a material adverse impact on the company’s financial position or risk profile.

Regulatory Compliance and Approval

The transaction was reviewed and approved by both the Audit Committee and the Board of Directors of Shlokka Dyes Limited. As per the disclosure made under Regulation 30 of the SEBI LODR Regulations, read with the SEBI Master Circular dated January 30, 2026, the value of the transaction (₹3.67 crore) is lower than 10% of the company’s standalone annual turnover for FY26 (₹81.94 crore) and also below 10% of the standalone net worth as of March 31, 2026 (₹85.36 crore). Consequently, the deal does not constitute a 'material related party transaction' requiring shareholder ratification under Section 188(1) of the Companies Act, 2013. No governmental or regulatory approvals are required for this acquisition. The completion of the transaction is expected within 30 days from the signing of the Business Transfer Agreement.